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A B S T R A C T
Purpose: The effects of epilepsy and seizures on cardiac functions have been documented, and this
association has drawn attention in recent years. The aim of this study was to investigate left ventricle
(LV) diastolic function by tissue Doppler imaging (TDI) in patients with newly diagnosed and untreated
primary generalized epilepsy (PGE).
Method: Thirty newly diagnosed and untreated PGE patients (14 females, mean age 27.60  9.64 years)
and 30 healthy age- and gender-matched control subjects (14 females, mean age 29.47  6.89 years) were
included in the study. The LV functions of the study cohort were evaluated using conventional
echocardiography and TDI.
Results: There were no signiﬁcant differences found between the two groups regarding the left atrium
diameter, left atrium volume index, interventricular septum and posterior wall thickness, LV end
diastolic diameter, and LV end diastolic volume (p > 0.05 for each parameter). PGE patients exhibited a
higher LV end systolic diameter and LV end systolic volume compared to the controls (p < 0.001 for each
parameter). Thus, the fractional shortening and ejection fraction were lower in the PGE patients
(p < 0.001 for each parameter). The E to average e0 ratio, the most important noninvasive indicator of LV
ﬁlling pressure, was signiﬁcantly higher in patients with PGE (8.31  2.78 vs. 6.95  1.26, p = 0.018).
Conclusion: The present study reports the systolic and diastolic dysfunction of LV in newly diagnosed
PGE patients compared to control subjects. Taken together, the screening of epileptic patients using
conventional echocardiography and TDI may be useful to evaluate the effects of epilepsy on cardiac
functions.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy and seizures may have a profound effect on cardiac
function. In patients with seizures, epileptic discharges are thought
to propagate to the central autonomic network and change or
disturb the normal autonomic control of vital cardiac functions.
Typical cardiovascular manifestations of epilepsy include altera-
tions in heart rate and rhythm, blood pressure, and electrocardio-
gram.1
It is well known that patients with epilepsy have an increased
risk for sudden unexpected death (SUDEP). The risk of SUDEP is
increased 242- to 403-fold in the epileptic population compared to
the general population. The exact mechanism of SUDEP is not* Corresponding author. Tel.: +90 322 231 07 91; fax: +90 322 327 12 98.
E-mail addresses: muhammetbilgi@hotmail.com, muhammetbilgi@gmail.com
(M. Bilgi).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.03.015completely understood however, it is most likely multifactorial.
The most important risk factor for SUDEP is the frequency of
generalized tonic-clonic seizures.4 Seizure-related cardiac dys-
function is thought to be one important mechanism of SUDEP.
Thus, alterations in cardiac functions in epileptic patients have
become an issue of increasing interest.
Left ventricular diastolic dysfunction (LVDD) is common in
cardiac disease and contributes to the development of heart
failure. Approximately half of the patients with newly diagnosed
heart failure have normal or near normal global ejection fractions.
These patients have been identiﬁed to have diastolic heart failure
or heart failure with preserved ejection fraction (HFPEF).5 LVDD is
one of the principal causes of HFPEF.6 A recent review reported a
LVDD prevalence of 27.3% in the general population.7 The ‘‘gold
standard’’ in evaluating LV diastolic functions is the measurement
of LV ﬁlling pressures. However, this method is invasive and not
practical. Echocardiography may be used to noninvasively evaluate
both systolic and diastolic cardiac functions.8 Doppler studies arevier Ltd. All rights reserved.
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by traditional mitral ﬂow Doppler studies include E wave velocity,
A wave velocity, E wave deceleration time (DT), isovolumetric
relaxation time (IVRT), and the E/A ratio. The data obtained using
this method are preload dependent and exhibit a lower accuracy.
Within the last two decades, tissue Doppler imaging (TDI) has been
developed to enhance the accuracy of diastolic heart function
analyses.9 TDI measures the diastolic and systolic velocities of the
ventricular walls and mitral annulus, and is less affected by loading
conditions.10 The mitral annulus velocity as determined by TDI is a
relatively preload independent variable and is superior to
conventional mitral Doppler indices.11 These parameters may be
used to estimate the LV ﬁlling pressures.12 Thus, TDI is currently
used worldwide to evaluate LV diastolic function.13 The ratio of the
pulsed Doppler mitral E wave velocity to tissue-Doppler-derived
peak early diastolic velocity of the mitral annulus movement (E/e0)
correlates with the LV ﬁlling pressures.8 The European Society of
Cardiology recommends using the Doppler echocardiographic
index as a ﬁrst step in the diagnosis of HFPEF.5
The aim of this study was to investigate LV diastolic function
using TDI in patients with newly diagnosed and untreated primary
generalized epilepsy (PGE).
2. Material and methods
2.1. Patients
In this single-center prospective study, patients with electro-
clinical or only clinical diagnosis of idiopathic generalized epilepsy
(IGE), who had at least one electroencephalogram (EEG) available,
were recruited consecutively among those who presented to the
outpatient epilepsy clinic at Medical Faculty of Baskent University
from 2007 through 2011. Thirty newly diagnosed and untreated
PGE patients (14 females, mean age 27.60  9.64 years) and 30
healthy age- and gender-matched control subjects (14 females, mean
age 29.47  6.89 years) were included in this study. The patient’s
medical history was obtained, and the physical and neurological
examinations were performed by the same neurologist. Similarly, the
same cardiologist performed cardiac examinations on the patients
and interpreted their electrocardiograms.
The exclusion criteria included pregnancy, known coronary
artery disease, impaired liver or renal function, hypertension,
moderate or severe valvular heart disease, impaired left ventricu-
lar systolic function (ejection fraction < 50%), restrictive, hyper-
trophic, or dilated cardiomyopathies, congenital heart disease,
respiratory diseases, diabetes mellitus, malignancy, smoking,
excessive alcohol consumption, hyperlipidemia, history of previ-
ous cardiac surgery, severe mitral annular calciﬁcation, atrial
ﬁbrillation or other severe arrhythmias, the presence of permanent
pacemakers or implantable deﬁbrillators, any medication usage,
and poor echocardiographic images.
The type of epilepsy was determined according to the guide-
lines of the International League Against Epilepsy and was based on
a detailed medical history obtained from the patients and/or
witnesses, physical and neurological examinations, EEGs, and
neuroradiological ﬁndings.14 The diagnosis of epilepsy was newly
established in the PGE patient group in which anti-epileptic drugs
had not been previously used. The epileptic subtypes were
determined as follows: 20 patients with primary generalized
tonic clonic (GTC) seizures, 4 patients with primary GTC, absence
and myoclonic seizures, 4 patients with primary GTC and
myoclonic seizures, and 2 patients with only myoclonic seizures.
The average age of seizure onset was 23.5  10.5 years. The duration
of the seizures ranged from one day to 30 years [9 patients: 3–14
years (average 7.4  3.97 years), 9 patients: 1 year, 6 patients: 1–6
months (average 3.7  2.3 months), 5 patients: 1–7 days, 1 patient:two seizures in the last 30 years]. The frequency of the seizures was
15 or more per year in 36.7% of the patients and between 1 and 6 per
year in 63.3% of the patients. The reasons for the delayed visit to a
physician were documented as due to low socioeconomic status and
the patients’ and their families’ disafﬁrmation of the disease due to
sociocultural factors. Any etiology for epilepsy was not identiﬁed. Six
of the patients had a history of epilepsy in their second and third
degree relatives. Neurological examination was normal in all of the
patients. Cerebral magnetic resonance imaging was performed
according to epileptic protocol and was evaluated by a radiologist
trained in epileptic imaging. The patients did not have any structural
pathologies. For each patient, we obtained a 15-min EEG recording
with 5-min hyperventilation and intermittent photic stimulation
(IPS) at 2, 6, 10, 14 and 18 Hz (10 s IPS and 10 s rest) using a 14-
channel EEG recorder. We used the international 10–20 system for
electrode placement. All recordings were obtained in the interictal
state without sleep deprivation. The interictal EEG was normal in 17
of the 30 patients. In the remaining 13 patients, 6 patients had a
bilateral diffuse epileptic activity disorder, 6 patients had bilateral
diffuse paroxysmal discharges of theta and sharp waves, and one
patient exhibited background rhythm irregularity formed by beta
waves.
2.2. Echocardiography
All of the patients were examined during a seizure-free period
of at least 24 h prior to the recordings, and none of the patients
reported seizures during the recording periods. All of the included
patients underwent an echocardiography with a commercially
available standard ultrasound diagnostic system (Vivid 7, GE
Vingmed, Horten, Norway) equipped with a 2.5-MHz phased-array
transducer. The images were obtained in the left lateral decubitus
position after 10 min of rest. All of the patients were evaluated by
M-mode, two-dimensional, pulse-wave Doppler and TDI echocar-
diography. The diameters of the LV and left atrium, and the
thicknesses of the interventricular septum and LV posterior wall
were measured by the M-mode technique according to the
recommendations of the American Society of Echocardiography.15
The peak velocities of the early (E) and late (A) diastolic ﬁlling, DT,
and IVRT were derived from Doppler recordings of the mitral valve
inﬂow and aortic valve outﬂow.16 For TDI, the ﬁlter setting was
lowered, and the Nyquist limit was adjusted (range, 15–20 cm/s).
The gain was minimized to allow for a clear tissue signal with
minimal background noise. For TDI recordings from the apical
window, a 5-mm sample volume was located at the septal and
lateral sides of the mitral valve annulus in the 4-chamber view and
at the anterobasal and inferior sites in the 2-chamber view.16
Measurements were recorded with simultaneous electrocardiog-
raphy at a sweep speed of 50–100 mm/s. The peak systolic velocity
(s0), early (e0) and late (a0) diastolic velocities, and e0/a0 ratio were
measured. The E/average e0 ratio was calculated by dividing the
transmitral E peak by the e0 average from the 4 acquisition sites.
The LVDD diagnosis and staging were performed according to the
recommendations of the European Association of Echocardiogra-
phy.17 The LVDD was identiﬁed if the mitral annular septal e0
velocity was lower than 8 cm/s, if the mitral annular lateral e0
velocity was lower than 10 cm/s, and if the left atrium volume
index was higher than 34 mL/m2. LVDD has three grades (I, II, and
III). When the LVDD was detected, the grade was estimated using
Doppler parameters, including the E/A ratio, DT, IVRT, and the E/
average e0 ratio as well as ancillary techniques, if necessary.17 The
ejection fraction was calculated according to the Teicholz
formula.18 All of the echocardiographic studies were digitally
recorded for off-line analysis. All of the measurements were
averaged from three cardiac cycles to minimize the respiratory
variability and were blindly performed by a single independent
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approved by the local Ethics Committee and all of the subjects gave
their written informed consent. The study was conducted
according to the Declaration of Helsinki.
2.3. Statistics
All of the statistical analyses were performed using the SPSS
software package, version 9.0 for Windows (SPSS Inc., Chicago, IL,
USA). The continuous variables were expressed as the mean  SD
and the categorical variables as numbers and percentages. The
Kolmogoroff–Smirnoff test was used to determine whether the data
were normally distributed. Differences between the independent
groups were assessed using an unpaired t-test for continuous
variables and a Chi-square test for categorical variables. The
Mann–Whitney U-test was used for variables that were not normally
distributed. The relationships of epilepsy duration and seizure
frequency with left ventricular ejection fraction and E/e0 ratio were
examined using the Spearman correlation test. Statistical signiﬁcance
was deﬁned as p < 0.05.
3. Results
The demographic and echocardiographic data of the patient and
control groups are presented in Table 1. The age, gender, and body
mass index were comparable between these two groups, and there
were no statistically signiﬁcant differences regarding left atrium
diameter and left atrium volume index (p = 0.64 and p = 0.38,
respectively). The interventricular septum and posterior wall
thickness were similar between the two groups as well (p = 0.47Table 1
Demographic and echocardiographic data.
PGE (n = 30) Control (n = 30) p-Value
Female (n, %) 14(46.6%) 14(46.6) p = 1
Age (years) 27.60  9.64 29.47  6.89 p = 0.39
BMI (kg/m2) 23.43  1.53 23.13  1.10 p = 0.38
Heart rate (beat/min) 77.60  12.24 78.40  10.44 p = 0.78
Left atrial diameter (mm) 34.46  3.96 34.93  3.73 p = 0.64
Left atrial volume (mL) 51.70  5.94 52.40  5.59 p = 0.64
Left atrial volume index
(mL/m2)
29.62  3.46 30.40  3.43 p = 0.38
Interventricular septum
thickness (mm)
9.48  2.21 10.01  1.46 p = 0.47a
Posterior wall thickness
(mm)




45.06  3.49 43.06  4.93 p = 0.075
End-systolic diameter
(mm)
29.10  3.70 24.63  4.18 p < 0.001
End-diastolic volume (mL) 93.55  16.94 84.94  22.32 p = 0.098
End-systolic volume (mL) 33.32  10.04 22.55  9.08 p < 0.001
Fractional shortening (%) 35.54  5.22 43.01  5.36 p < 0.001
Ejection fraction (%) 64.78  6.58 74.06  6.13 p < 0.001
Mitral inﬂow velocities
E (cm/s) 112.10  16.66 85.20  15.27 p < 0.001
A (cm/s) 77.77  16.66 74.47  14.28 P = 0.41
E/A ratio 1.48  0.29 1.19  0.37 p = 0.001
E deceleration time (ms) 244.50  61.84 194.07  44.54 p = 0.001
Isovolumic relaxation
time (ms)
101.07  12.24 89.83  15.51 p = 0.003
Mitral annular velocities
Lateral e0 (cm/s) 16.20  3.26 14.23  4.36 p = 0.053
Septal e0 (cm/s) 13.07  2.66 10.93  3.25 p = 0.007
Average e0 14.17  2.73 12.65  3.23 p = 0.055
E/average e0 8.31  2.78 6.95  1.26 p = 0.018
PGE: primary generalized epilepsy, BMI: body mass index, E: peak mitral inﬂow
early velocity, A: peak mitral inﬂow late velocity, e0: peak early diastolic annular
velocity.
a Non-parametric tests were used.and p = 0.11, respectively). Although the LV end diastolic diameter
and LV end diastolic volume were comparable (p = 0.075 and
p = 0.098, respectively), the LV end systolic diameter and LV end
systolic volume were statistically higher in the PGE patients
(p < 0.001 for both parameters). The LV fractional shortening and
ejection fraction were lower in the PGE patients when compared to
the control group (p < 0.001 for both parameters). The E wave
velocity, E/A ratio, DT and IVRT were signiﬁcantly higher in the PGE
group (p < 0.001, p < 0.001, p < 0.001, and p = 0.003, respectively).
The average e0 was indifferent between the groups (p = 0.055). The
E/average e0, which is the most important noninvasive indicator of
LV ﬁlling pressure, was signiﬁcantly higher in the PGE patients
(8.31  2.78 vs. 6.95  1.26 in controls, p = 0.018). One patient in
each group was diagnosed with LVDD (3.3% for each group). Of those
patients, the patient with PGE had a LVDD of grade III and the control
subject had a LVDD of grade II. Epilepsy duration and seizure
frequency showed no signiﬁcant correlations with left ventricular
ejection fraction and E/average e0 ratio (for all, p > 0.05).
4. Discussion
Normal diastolic function enables normal LV ﬁlling at rest and
during exercise without the abnormal elevation of LV ﬁlling
pressures. LVDD may be the ﬁrst pathological ﬁnding of an
underlying cardiac disease.7 It has been associated with an
increased risk of cardiovascular events and death.19 Elevated
ﬁlling pressures are the main physiological consequence of
diastolic dysfunction.20 When assessing LV diastolic performance,
the tissue Doppler is more reliable than the conventional Doppler
because it is not as inﬂuenced by the loading conditions and the
TDI measurements are more reproducible.21 Diastolic abnormali-
ties may be detected using TDI, even before the onset of
hemodynamic abnormalities in subjects who have normal
conventional echocardiography.22 The E/e0 ratio is the single best
parameter to predict the mean LV ﬁlling pressures.8 This ratio is
proportional to LVDD severity. In this study, newly diagnosed PGE
patients had a higher E/e0 ratio compared to control subjects, which
indicates increased LV ﬁlling pressures in PGE patients and thus
impaired LV diastolic function. During ventricular diastole, the left
atrium is directly exposed to the LV ﬁlling pressure. Thus, an
increased left atrium size and volume may reﬂect the duration and
severity of the diastolic dysfunction.23 Similar ﬁndings in the left
atrium diameter and left atrium volume index between both
groups suggest that LVDD in PGE is not long-term or very severe. In
this study, only one case in each group (3%) was diagnosed with
LVDD upon examination in light of recent recommendations. This
rate is lower than that of the general population. LVDD prevalence
increases with age. Both the patients and control subjects have a
younger mean age, and patients with disorders that may cause
LVDD have been excluded from the study. These reasons may
explain the lower LVDD rates in our study cohort.
Another important ﬁnding in this study is the lower LV
fractional shortening and ejection fraction values, which resulted
from a statistically signiﬁcant increase in the LV end systolic
diameter and LV end systolic volume. The mean LV ejection
fraction in PGE patients were higher than the normal threshold,
which was 50%. Although this takes away from the clinical
importance of this decrease in fractional shortening and ejection
fraction, it is still an important indicator of adverse outcomes on LV
systolic functions.
Lack of signiﬁcant correlations between epilepsy duration and
seizure frequency and LV systolic and diastolic dysfunction
suggests that adverse cardiac effects detected in PGE patients
may not be cumulative.
Taken together, the ﬁndings in this study revealed a statistically
signiﬁcant deterioration of LV systolic and diastolic functions in
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over the recent years, and these effects are thought to be
multifactorial. In this regard, the LV systolic and diastolic functions
may be affected by various pathophysiological mechanisms in
epileptic patients.
4.1. Autonomic dysfunction
Autonomic dysfunction in epileptic patients may be one of
the mechanisms responsible for cardiac effects. Cardiovascular
autonomic neuropathy (CAN) results in abnormalities in heart
rate control and vascular dynamics. Autonomic dysfunction has
been noted in 56.3% of patients with chronic refractory
epilepsy.24 Resting diastolic dysfunction is independently
associated with the abnormal heart rate recovery, which is a
marker of autonomic dysfunction.25 Autonomic abnormalities
have also been identiﬁed in patients with HFPEF.26,27 The
autonomic nervous system affects cardiac myocyte calcium
handling,28 and cardiac autonomic abnormalities are associated
with diastolic dysfunction.29
To the best of our knowledge, there have been no published
studies evaluating the relationship between autonomic dys-
function and LV diastolic function in epileptic patients;
however, there have been studies examining diabetic patients.
One of the main theories for the cause of diabetic cardiomyop-
athy is CAN.30 CAN is a common form of autonomic dysfunction
in patients with diabetes mellitus.31
Heart rate variability (HRV) is a mirror of neuronal inﬂuences
on the cardiac pacemaker, which is an important function of the
autonomic nervous system. The HRV was lower in patients with
chronic refractory epilepsy, which potentially resulted from a
parasympathetic or vagal reduction.32 A low HRV can make
patients more susceptible to tachyarrythmia. Patients with long-
lasting and multiple seizures are more prone to chronic
dysfunction of autonomic cardiac control. In patients with
newly diagnosed (median time 27 months) and untreated
epilepsy, no differences were found in HRV.33 In contrast, the
autonomic functions of newly diagnosed epileptic patients were
assessed with a heart rate recovery measurement used in
another study and it was reported that increased heart rate
recovery suggests of increased parasympathetic functions.34 On
the basis of the aforementioned data, we conclude that
autonomic dysfunction may affect the LV functions in newly
diagnosed PGE patients.
4.2. Vagus nerve
Heart failure is characterized by an autonomic imbalance
with a withdrawal of vagal activity and increased sympathetic
activity.35 During the early stages of heart failure, increased beta
adrenergic stimulation may be beneﬁcial, but long-term
stimulation causes increased myocyte apoptosis, ﬁbrous tissue
formation, and electrical instability, thereby resulting in
impaired ventricular performance.36 There have been case
reports documenting temporary LV systolic dysfunction after
seizures in epileptic patients with Tako Tsubo cardiomyopathy.
These patients were characterized with normal coronaries, and
thus excessive adrenergic discharge was thought to be
responsible for the etiology.37,38 Vagus nerve stimulation has
been shown to improve the quality of life in patients with
symptomatic heart failure and increase ejection fraction.39
Moreover, vagus nerve stimulation has been successfully
applied for many years to treat drug-resistant epilepsy.40 We
suggest that the vagus nerve may mediate a common
pathophysiological pathway between impaired LV functions
and epilepsy.4.3. Myocardial ischemia
Myocardial ischemia and related cardiac injuries may facilitate
LV systolic and diastolic dysfunction in PGE patients. An increased
heart rate has been observed during most seizures.41 Epileptic
seizures may cause excessive autonomic activation and may
precede myocardial damage via sympathetic overstimulation or
subendocardial ischemia. During the ictal and the immediate post-
ictal period, 40% of the patients demonstrated ST segment
depression in an electrocardiogram.42 Alehan et al. reported
elevated levels of brain natriuretic peptides and a cardiac-speciﬁc
fraction of creatine kinase in patients with seizures, which are the
ﬁrst evidence of subtle cardiac dysfunction in epileptic patients.43
5. SUDEP
There is evidence for an increase in cardiac autonomic
stimulation in patients with SUDEP.44 It has been reported that
there is cardiac ischemic damage, despite normal coronary
arteries, in the post mortem examinations of SUDEP victims.45
This may be due to repeated episodes of vasoconstriction and an
increase in sympathetic activity. Myocardial ﬁbrosis has already
been reported in patients with SUDEP.46 One of the causes of LV
stiffening is myocardial ﬁbrosis.47 Myocardial ﬁbrosis may also
cause LV systolic and diastolic dysfunction in PGE patients.
5.1. Study limitations
This study has several limitations. Despite normal EEG
examinations, the diagnosis of epilepsy was solely based on
clinical history in 17 patients. The fact that interictal EEG cannot
differentiate seizure types and different IGE syndromes makes
clinical history a key element in making the correct diagnosis of
epilepsy. More than 40% of patients with epilepsy may have one
normal interictal EEG. Studies investigating the ﬁrst and serial EEG
ﬁndings in patients with distinct IGE syndromes suggest that
antiepileptic treatment should be initiated based on clinical
history. Otherwise, time elapsed for documenting typical EEG
abnormalities can cause a signiﬁcant delay in the treatment of
patients with IGE.48–50 Another limitation of our study may be the
duration of EEG (15 min) at our center, which might have yielded a
higher frequency of normal EEGs in these patients. In addition,
psychological disturbances like anxiety and depression may affect
the autonomic nervous system, resulting in alterations in cardiac
functions. Use of special tests to uncover these conditions may
have excluded patients having psychological disturbances, and
thus eliminated this confounding effect.
6. Conclusion
The cardiac effects of epileptic seizures are thought to be
temporary and benign, however, this study demonstrated that
newly diagnosed PGE patients have impaired systolic and diastolic
functions when compared to control subjects. Screening epileptic
patients with traditional echocardiography and TDI may be useful
to evaluate the effects of epilepsy on cardiac functions.
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